Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Daniela Conrado"'
Autor:
Jenny‐Hoa Nguyen, Daniel Epling, Nancy Dolphin, Anne Paccaly, Daniela Conrado, John D. Davis, Nidal Al‐Huniti
Publikováno v:
CPT: Pharmacometrics & Systems Pharmacology, Vol 11, Iss 11, Pp 1458-1471 (2022)
Abstract A population pharmacokinetic (PopPK) model was previously developed for cemiplimab in patients with solid tumors, including advanced cutaneous squamous cell carcinoma (CSCC). Here, we update the existing PopPK model and characterize exposure
Externí odkaz:
https://doaj.org/article/d66296e49f744b368611427da7a3de74
Autor:
Klaus Romero, Daniela Conrado, Jackson Burton, Timothy Nicholas, Vikram Sinha, Sreeraj Macha, Malidi Ahamadi, Jesse Cedarbaum, John Seibyl, Kenneth Marek, Peter Basseches, Derek Hill, Ed Somer, Jill Gallagher, David T. Dexter, Arthur Roach, Diane Stephenson, for the Critical Path for Parkinson's (CPP) Consortium, the Parkinson's Progression Markers Initiative (PPMI)
Publikováno v:
Clinical and Translational Science, Vol 12, Iss 3, Pp 240-246 (2019)
The Critical Path for Parkinson's (CPP) Imaging Biomarker and Modeling and Simulation working groups aimed to achieve qualification opinion by the European Medicines Agency (EMA) Committee for Medical Products for Human Use (CHMP) for the use of base
Externí odkaz:
https://doaj.org/article/947d1d44d90d4ee39519d4068df35b29
Autor:
Sherwin K B, Sy, Rajendra P, Singh, Sireen, Shilbayeh, Rawan, Zmeili, Daniela, Conrado, Hartmut, Derendorf
Publikováno v:
Clinical pharmacology in drug development. 2(1)
The aim of the study is to investigate the influence of ABCB1(3435) and CYP3A5(6986) polymorphisms, tacrolimus troughs and clinical factors on the time of adverse events associated with tacrolimus in pediatric kidney transplant patients. Clinical dat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::18e784b6f1ad3680b758195ca4affbed
https://pubmed.ncbi.nlm.nih.gov/27121561
https://pubmed.ncbi.nlm.nih.gov/27121561